Responses
Clinical
Original research
Single-tablet regimen of emtricitabine/tenofovir disoproxil fumarate plus cobicistat-boosted elvitegravir increase adherence for HIV postexposure prophylaxis in sexual assault victims
Compose a Response to This Article
Other responses
No responses have been published for this article.